Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Chronic-Phase × palbociclib × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 62 Neoplasm Metastasis 11 Neoplasms 8 Ovarian Neoplasms 5 Endometrial Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Breast Diseases 4 Sarcoma 3 Recurrence 3 Pancreatic Neoplasms 3 Neoplasms by Site 3 Lymphoma, Non-Hodgkin 3 Leukemia, Myeloid, Acute 3 Head and Neck Neoplasms 3 Carcinoma, Renal Cell 3 Triple Negative Breast Neoplasms 2 Multiple Myeloma 2 Lymphoma 2 Lung Neoplasms 2 Liposarcoma 2 Kidney Neoplasms 2 Fallopian Tube Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Non-Small-Cell Lung 2 Advanced Solid Tumors 2 Advanced Breast Cancer 2 von Hippel-Lindau Disease 1 Xanthogranuloma, Juvenile 1 Wilms Tumor 1 Venous Thromboembolism 1

Interventions

nilotinib 6 asciminib 6 Dasatinib 6 Imatinib Mesylate 5 bosutinib 4 Cyclophosphamide 4 fludarabine phosphate 3 Whole-Body Irradiation 3 ruxolitinib 2 ponatinib 2 letermovir 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Mycophenolic Acid 2 Methotrexate 2 Melphalan 2 Cyclosporine 2 Busulfan 2 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 olverembatinib 1 decitabine and cedazuridine drug combination 1 Vorinostat 1 Valganciclovir 1 Therapeutics 1 Stem Cell Transplantation 1 Specimen Handling 1 Sirolimus 1 Rituximab 1 Practice Management, Medical 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡